Resultados: 25

    Guideline No. 420: cytomegalovirus Infection in Pregnancy

    J. obstet. gynaecol. Can; 43 (7), 2021
    To provide an update on current recommendations for cytomegalovirus (CMV) infection during pregnancy. The objectives of this guideline are: To improve perinatal care providers’ awareness of the consequences of maternal CMV infection for the fetus and the infant; To emphasize the importance of educating...

    Guideline No. 416: labour, delivery, and postpartum care for people with physical disabilities

    J. obstet. gynaecol. Can; 43 (6), 2021
    To describe evidence-based practice for managing the labour, delivery, and postpartum care of people with physical disabilities in Canada. This guideline addresses the needs of people with physical disabilities, with a focus on conditions that affect strength and mobility, as well as those that affect ne...

    Guideline No. 414: management of pregnancy of unknown location and tubal and nontubal ectopic pregnancies

    J. obstet. gynaecol. Can; 43 (5), 2021
    To provide an evidence-based algorithm to guide the diagnosis and management of pregnancy of unknown location and tubal and nontubal ectopic pregnancy. All patients of reproductive age. The implementation of this guideline aims to benefit patients with positive β-human chorionic gonadotropin results and...

    The Use of Dexamethasone in Patients with High-Grade Gliomas

    Patients with primary brain tumours often develop vasogenic edema and increased intracranial pressure. Corticosteroid therapy improves this in most patients, generally within 48 hours. As such, corticosteroid therapy is sometimes a necessary prerequisite to embarking on chemotherapy and radiotherapy foll...

    Guideline No. 417: prevention of venous thromboembolic disease in gynaecological surgery [Pré-print]

    The primary objective of this clinical practice guideline is to provide gynaecologists with an algorithm and evidence to guide the use of thromboprophylaxis in gynaecological surgery. All patients undergoing gynaecological surgery for benign or malignant indications. The implementation of this guideline ...

    Guideline No. 410: prevention, screening, diagnosis, and pregnancy Management for fetal neural tube defects

    J. obstet. gynaecol. Can; 43 (1), 2021
    This revised guideline is intended to provide an update on the genetic aspects, prevention, screening, diagnosis, and management of fetal neural tube defects. Target population: Women who are pregnant or may become pregnant. Neural tube defect screening should be offered to all pregnant women. For preven...

    Guideline No. 408: management of gestational trophoblastic diseases

    J. obstet. gynaecol. Can; 43 (1), 2021
    This guideline reviews the clinical evaluation and management of gestational trophoblastic diseases, including surgical and medical management of benign, premalignant, and malignant entities. The objective of this guideline is to assist health care providers in promptly diagnosing gestational trophoblast...

    Guideline No. 409: intrauterine fetal diagnostic testing in women with chronic viral infections

    J. obstet. gynaecol. Can; 42 (12), 2020
    This revised guideline provides updated information for the care of women with chronic viral infections who require intrauterine fetal diagnostic testing. Women with chronic viral infections who are pregnant or planning a pregnancy. Non-invasive screening tests for diagnosis: maternal serum placental ana...

    Guideline No. 401: sonographic cervical length in Singleton Pregnancies: techniques and clinical applications

    J. obstet. gynaecol. Can; 42 (11), 2020
    To assess the association between sonography-derived cervical length measurement and preterm birth. To describe the various techniques to measure cervical length using sonography. To review the natural history of the short cervix. To review the clinical uses, predictive ability, and utility of sonography...

    Guideline No. 405: screening and counselling for alcohol consumption during pregnancy

    J. obstet. gynaecol. Can; 42 (9), 2020
    To establish national standards of care for screening and counselling pregnant women and women of child-bearing age about alcohol consumption and possible alcohol use disorder based on current best evidence. Health care providers who care for pregnant women and women of child-bearing age. Pregnant women ...